Immunization with pneumolysin protects against both retinal and global damage caused by streptococcus pneumoniae endophthalmitis

Journal of Ocular Pharmacology and Therapeutics

Volumn 26, Issue 6, 2010, Pages 571-577

  Sanders, Melissa E ^a   Norcross, Erin W ^a   Moore, Quincy C ^a   Fratkin, Jonathan ^a   Thompson, Hilary ^b   Marquart, Mary E ^a  

^a UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^b LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G; PHOSPHATE BUFFERED SALINE; PNEUMOLYSIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY TITER; AQUEOUS HUMOR; ARTICLE; BACTERIAL GROWTH; BACTERIUM ISOLATE; COLONY FORMING UNIT; CONJUNCTIVA; CONTROLLED STUDY; CYTOLYSIS; DISEASE SEVERITY; ENDOPHTHALMITIS; HISTOLOGY; IMMUNIZATION; NONHUMAN; PNEUMOCOCCAL INFECTION; RETINA INJURY; SLIT LAMP; STROMA; SURVIVAL; VITREOUS BODY; VITREOUS DISEASE;

ANIMALS; BACTERIAL PROTEINS; ENDOPHTHALMITIS; EYE; IMMUNOGLOBULIN G; PNEUMOCOCCAL INFECTIONS; RABBITS; RETINA; SEVERITY OF ILLNESS INDEX; STREPTOCOCCUS PNEUMONIAE; STREPTOLYSINS; TIME FACTORS; VACCINATION;

EID: 78649707314     PISSN: 10807683     EISSN: None     Source Type: Journal    
DOI: 10.1089/jop.2010.0077     Document Type: Article

References (34)

1. Callegan, M.C., Booth, M.C., Jett, B.D., and Gilmore, M.S. Pathogenesis of gram-positive bacterial endophthalmitis. Infect. Immun. 67:3348-3356, 1999.
2. Callegan, M.C., Engelbert, M., Parke, D.W., II, Jett, B.D., and Gilmore, M.S. Bacterial endophthalmitis: epidemiology, therapeutics, and bacterium-host interactions. Clin. Micro-biol. Rev. 15:111-124, 2002.
3. Han, D.P., Wisniewski, S.R., Wilson, L.A., et al. Spectrum and susceptibilities of microbiologic isolates in the En-dophthalmitis Virectomy Study. Am. J. Ophthalmol. 122:1-17, 1996.
4. Tweten, R.K. Cholesterol-dependent cytolysins, a family of versatile pore-forming toxins. Infect. Immun. 73:6199-6209, 2005.
5. Baba, H., Kawamura, I., Kohda, C., et al. Essential role of domain 4 of pneumolysin from Streptococcus pneumoniae in cytolytic activity as determined by truncated proteins. Bio-chem. Biophys. Res. Commun. 281:37-44, 2001.
6. Boney, B.B., Gilbert, R.J., Andrew, P.W., Byron, O., and Watts, A. Structural analysis of the protein/lipid complexes associated with pore formation by the bacterial toxin pneu-molysin. J. Biol. Chem. 276:5714-5719, 2001.
7. Kelly, S.J., and Jedrzejas, M.J. Structure and molecular mechanism of a functional form of pneumolysin: a cholesterol-dependent cytolysin from Streptococcus pneumoniae. J. Struct. Biol. 132:72-81, 2000.
8. Fickl, H., Cockeran, R., Steel, H.C., et al. Pneumolysin-mediated activation of NFkappaB in human neutrophils is antagonized by docosahexaenoic acid. Clin. Exp. Immunol. 140:274-281, 2005.
9. Ratner, A.J., Hippe, K.R., Aguilar, J.L., et al. Epithelial cells are sensitive detectors of bacterial pore-forming toxins. J. Biol. Chem. 281:12994-12998, 2006.
10. Paton, J.C., Rowan-Kelly, B., and Ferrante, A. Activation of human complement by the pneumococcal toxin pneumoly-sin. Infect. Immun. 43:1085-1087, 1984. (Pubitemid 14192004)
11. Rubins, J.B., Charboneau, D., Fasching, C., et al. Distinct roles for pneumolysin's cytotoxic and complement activities in the pathogenesis of pneumococcal pneumonia. Am. J. Respir. Crit. Care Med. 153:1339-1346, 1996. (Pubitemid 26112601)
12. Rubins, J.B., and Janoff, E.N. Pneumolysin: a multifunctional pneumococcal virulence factor. J. Lab. Clin. Med. 131:21-27, 1998.
13. Jounblat, R., Kadioglu, A., Mitchell, T.J., and Andrew, P.W. Pneumococcal behavior and host responses during bron-chopneumonia are affected differently by the cytolytic and complement-activating activities of pneumolysin. Infect. Immun. 71:1813-1819, 2003.
14. Ng, E.W., Samiy, N., Cousins, F.V., et al. Implication of pneumolysin as a virulence factor in Streptococcus pneumo-niae endophthalmitis. Retina 17:521-529, 1997.
15. Ng, E.W., Costa, J.R., Samiy, N., et al. Contribution of pneu-molysin and autolysin to the pathogenesis of experimental pneumococcal endophthalmitis. Retina 22:622-632, 2002.
16. Thornton, J., and McDaniel, L.S. THP-1 monocytes up-regulate intercellular adhesion molecule 1 in response to pneumolysin from Streptococcus pneumoniae. Infect. Immun. 73:6493-6498, 2005.
17. Zhang, Q., Choo, S., and Finn, A. Immune responses to novel pneumococcal proteins pneumolysin, PspA, PsaA, and CbpA in adenoidal B cells from children. Infect. Immun. 70:5363-5369, 2002.
18. Callegan, M.C., Jett, B.D., Hancock, L.E., and Gilmore, M.S. Role of hemolysin BL in the pathogenesis of extraintestinal Bacillus cereus infection assessed in an endophthalmitis model. Infect. Immun. 67:3357-3366, 1999.
19. Sriskandan, S., Ferguson, M., Elliot, V., Faulkner, L., and Cohen, J. Human intravenous immunoglobulin for experimental streptococcal toxic shock: bacterial clearance and modulation of inflammation. J. Antimicrob. Chemother. 58: 117-124, 2006.
20. Harlow, E., and Lane, D., eds. Using Antibodies: A Laboratory Manual. Cold Spring Harbor: Cold Spring Harbor Laboratory Press; 1999.
21. Crowder, M.J., and Hand, D.J. Monographs on Statistics and Applied Probability 41. Analysis of Repeated Measures. 1st ed. Boca Raton: Chapman & Hall/CRC; 1990; p. 268.
22. Edwards, D., and Berry, J.J. The efficiency of simulation-based multiple comparisons. Biometrics 43:913-928, 1987.
23. Sheskin, D.J. Handbook of Parametric and Nonparametric Statistical Procedures. 2nd ed. Boca Raton: Chapman & Hall/CRC; 2000.
24. Recchia, F.M., Busbee, B.G., Pearlman, R.B., Carvalho-Recchia, C.A., and Ho, A.C. Changing trends in the micro-biologic aspects of postcataract endophthalmitis. Arch. Ophthalmol. 123:341-346, 2005.
25. Beck, A.D., Grossniklaus, H.E., Hubbard, B., et al. Pathologic findings in late endophthalmitis after glaucoma filtering surgery. Ophthalmology 107:2111-2114, 2000.
26. He, X., and McDaniel, L.S. The genetic background of Streptococcus pneumoniae affects protection in mice immunized with PspA. FEMS Microbiol. Lett. 269:189-195, 2007.
27. Moore, Q.C., III, Johnson, L., Repka, M., and McDaniel, L.S. Immunization with PspA incorporated into a poly(exthylene oxide) matrix elicits protective immunity against Streptococcus pneumoniae. Clin. Vaccine Immunol. 14:789-791, 2007.
28. Ferreira, D.M., Darrieux, M., Silva, D.A., et al. Characterization of protective mucosal and systemic immune responses elicited by pneumococcal surface protein PspA and PspC nasal vaccines against a repiratory pneumococcal challenge in mice. Clin. Vaccine Immunol. 16:636-645, 2009.
29. Helms, C.M. Prevention of pneumococcal pneumonia by immunization with pneumococcal polysaccharide vaccine (Pneumovax). J. Iowa Med. Soc. 68:282-283, 1978.
30. Committee on Infectious Diseases. Policy statement: recommendations for the prevention of pneumococcal infections, including the use of pneumococcal conjugate vaccine (Prevnar), pneumococcal polysaccharide vaccine, and antibiotic prophylaxis. Pediatrics 106:362-366, 2000.
31. Green, S.N., Sanders, M., Moore, Q.C., et al. Protection from Streptococcus pneumoniae keratitis by passive immunization with pneumolysin antiserum. Invest. Ophthalmol. Vis. Sci. 49:290-294, 2008.
32. Miller, J.J., Scott, I.U., Flynn, H.W., et al. Endophthalmitis caused by Streptococcus pneumoniae. Am. J. Ophthalmol. 138: 231-236, 2004.
33. Soriano, F., Perez-Trallero, E., Pallares, R., et al. Streptococcus pneumoniae endophthalmitis: a study of 36 cases with special reference to antibiotic resistance and treatment options. Clin. Microbiol. Infect. 2:519-526, 2006.
34. Norcross, E.W., Sanders, M.E., Moore, Q., III, et al. Comparative efficacy of besifloxacin and other fluoroquinolones in a prophylaxis model of penicillin-resistant Streptococcus pneumoniae rabbit endophthalmitis. J. Ocul. Pharmacol. Ther. 26:237-243, 2010.